MiScale vs Palexy: Revenue, Funding & Team Size Compared
MiScale generates $1.2M in revenue; Palexy generates $1.2M. MiScale and Palexy are close to the same size by revenue. The table below compares MiScale and Palexy on funding, valuation, customers, team size and headquarters — every figure GetLatka has verified for each company.
| Company |  MiScaleThis company |  Palexy |
|---|---|---|
| Revenue | $1.2M | $1.2M |
| Funding raised | Not disclosed | $1.2M |
| Customers | Not disclosed | 59 |
| Team size | 22 | 13 |
| Founded | 2008 | 2019 |
| HQ | Not disclosed | Singapore |
Want the full dataset? GetLatka tracks revenue, funding and team history for thousands of SaaS companies, with charts, growth rates and founder interviews.
MiScale at a glance
MiScale generates $1.2M in revenue with 22 employees.
- Revenue
- $1.2M
- Team size
- 22
- Founded
- 2008
MiScale integrates personalized web services into a novel enterprise scale kiosk and distributes them to health management organizations including health clubs, pharmacies and assisted living facilities.Web-based admin accounts give health…
Palexy at a glance
Palexy generates $1.2M in revenue with 13 employees, headquartered in Singapore.
- Revenue
- $1.2M
- Funding
- $1.2M
- Customers
- 59
- Team size
- 13
- Founded
- 2019
AI-powered SaaS tools to empower brick and mortar retail to digitize the in-store experience and optimize the operational efficiency
Other MiScale alternatives
MiScale competes with more than the companies on this page. Browse the full alternative lists to compare revenue, funding and team size across the category.
MiScale vs Palexy: frequently asked questions
Is MiScale or Palexy bigger?
MiScale is the bigger company by revenue, at $1.2M against $1.2M for Palexy.
How much revenue does MiScale make?
MiScale generates $1.2M in annual revenue with a team of 22.
How much revenue does Palexy make?
Palexy generates $1.2M in annual revenue with a team of 13.
How much funding has Palexy raised?
Palexy has raised $1.2M in total funding since it was founded in 2019.